Alligator Bioscience AB (publ) (STO: ATORX)
Sweden
· Delayed Price · Currency is SEK 0.503
-0.076 (-13.13%)
Nov 20, 2024, 5:29 PM CET
Alligator Bioscience AB Revenue
Alligator Bioscience AB had revenue of 1.50M SEK in the quarter ending September 30, 2024, a decrease of -92.40%. This brings the company's revenue in the last twelve months to 27.77M, down -58.88% year-over-year. In the year 2023, Alligator Bioscience AB had annual revenue of 59.25M with 64.58% growth.
Revenue (ttm)
27.77M
Revenue Growth
-58.88%
P/S Ratio
12.55
Revenue / Employee
590.94K
Employees
58
Market Cap
381.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 59.25M | 23.25M | 64.58% |
| Dec 31, 2022 | 36.00M | 22.67M | 170.14% |
| Dec 31, 2021 | 13.33M | 7.81M | 141.65% |
| Dec 31, 2020 | 5.52M | 1.16M | 26.55% |
| Dec 31, 2019 | 4.36M | -22.67M | -83.88% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |